LncRNA MEG3 Regulates Imatinib Resistance in Chronic Myeloid Leukemia via Suppressing MicroRNA-21-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

LncRNA MEG3 Regulates Imatinib Resistance in Chronic Myeloid Leukemia via Suppressing MicroRNA-21

Published:2017-09-01 Issue:5 Volume:25 Page:490-496
ISSN:2005-4483
Container-title:Biomolecules & Therapeutics
language:en
Short-container-title:Biomolecules & Therapeutics

Author:

Zhou Xiangyu¹,Yuan Ping²,Liu Qi³,Liu Zhiqiang⁴

Affiliation:

1. Department of Vascular and Thyroid, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, China

2. Department of Neurology, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, China

3. Department of Pediatrics, Nanchong Central Hospital, Nanchong, Sichuan 637000, China

4. Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, Texas 77054, USA

Publisher

The Korean Society of Applied Pharmacology

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Biochemistry

Link

http://pdf.medrang.co.kr/BT2/2017/025/BT025-05-04.pdf

Reference29 articles.

1. A Multi-centric Bioequivalence Trial in Ph+ Chronic Myeloid Leukemia Patients to Assess Bioequivalence and Safety Evaluation of Generic Imatinib Mesylate 400 mg Tablets

2. Roots of Clinical Resistance to STI-571 Cancer Therapy

3. Targeting autophagy potentiates tyrosine kinase inhibitor–induced cell death in Philadelphia chromosome–positive cells, including primary CML stem cells

4. Gene silencing by DNA methylation in haematological malignancies

5. BCR-ABL1 mutation development during first-line treatment with dasatinib or imatinib for chronic myeloid leukemia in chronic phase

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. microRNA 21 and long non-coding RNAs interplays underlie cancer pathophysiology: A narrative review;Non-coding RNA Research;2024-09

2. lncRNAs: New players of cancer drug resistance via targeting ABC transporters;IUBMB Life;2024-08

3. Long non-coding RNAs: emerging functional players in the pathobiology and progression of myeloid leukemia;Frontiers in RNA Research;2024-05-31

4. MEG3 in hematologic malignancies: from the role of disease biomarker to therapeutic target;Pharmacogenetics and Genomics;2024-05-14

5. Unveiling IL6R and MYC as Targeting Biomarkers in Imatinib-Resistant Chronic Myeloid Leukemia through Advanced Non-Invasive Apoptosis Detection Sensor Version 2 Detection;Cells;2024-04-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3